Accolade beats analyst estimates, Teladoc’s optimism, and more JPM health tech news
In the latest edition of STAT's health tech newsletter: Accolade jumps on positive business outlook, Teladoc makes its case for sustained growth, and more.
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Teladoc makes its case for sustained growth
Teladoc CEO Jason Gorevic used the JPM 2024 stage to explain why the company believes it’s got plenty of “running room” to grow its integrated care business that connects people to a host of virtual health care services. During the pandemic, Teladoc spent years building awareness and signing up health plans and employers as customers. The company now hopes to generate more revenue from its existing clients, both by engaging with more of the 90 million people eligible for its services, and by selling more services to its customers.
What's Your Reaction?
